“Mr. Speaker, I would first like to congratulate my colleague on this excellent bill. I know he has worked very hard, consulted several experts and sought a range of opinions. It really is a remarkable piece of work. Some people fear that pharmaceutical companies might use the special access programs to circumvent the usual authorization procedures. Does the member have a view on this matter?”
Statement grade
A–
The average of Signal, Relevance, Respect and Clarity is 90. The grade is held to 88, 30 above Signal.
88 / 100, held down by Signal
A score under 50 is red. Choose a measurement to see where it lost points and why; choose it again to clear.
Thanks 11%Aside 24%Claims 64%
This view breaks the statement into its steps and names what each one does.
Mr. Speaker, Thanks · 15 wordsI would like to thank the hon. member for asking me another question in French.ThanksAside · 32 wordsIt is a good question, but I find it difficult to answer it in French.It might be better if I answered it in English.This is something that I struggled with.AsideClaims · 85 wordsWe do not want companies to have their drugs go on the pre-approved drug list rather than seeking approval for them.There are provisions that would allow the minister to require the company to give reasons why the companies are not seeking approval from Health Canada and to remove the drug from the pre-approved drug list if it thinks it is necessary.1I contemplated the possibility of putting penalty provisions in if a company were to use this process to circumvent authorization by Health Canada—